Biological evaluation of undifferentiated carcinoma of the esophagus

被引:22
作者
Matsumoto, M
Natsugoe, S
Nakashima, S
Shimada, M
Nakano, S
Kusano, C
Baba, M
Takao, S
Matsushita, Y
Aikou, T
机构
[1] Kagoshima Univ, Fac Med, Dept Surg 1, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Dept Pathol 2, Kagoshima 890, Japan
关键词
undifferentiated carcinoma; esophageal carcinoma; biological feature; immunohistochemistry;
D O I
10.1007/BF02523655
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Patients with undifferentiated carcinoma of the esophagus (UEC) are rare and have a poor prognosis compared with those with differentiated squamous cell carcinomas (DECs). We compared clinicopathological and biological Features of UEC and DEC, with emphasis on markers for epithelial cell origin. proliferation, and cell-cell adhesion. Methods: Seven patients with UEC were compared with 21 with DEC. Immunohisochemical studies were performed by using monoclonal antibodies to cytokeratin, epithelial membrane antigen, p53, p21(WAF1/C1P1), Ki-67, E-cadherin, desmoglein-1. and thrombomodulin. Results: Patients with UEC had a poorer prognosis because of hematogenous metastasis at the time of presentation (mean survival, 6.5 +/- 6.2 vs. 35.5 +/- 28.9 months: P < .05), Immunohistochemical findings for cytokeratin and epithelial membrane antigen suggest that some UECs had epithelial origins. The following immunohistochemical profile of UEC was consistent with its highly malignant properties: (1) reduced or negative expression of cell-cell adhesion molecules such as E-cadherin, desmoglein-1, and thrombomodulin, (2) high positive rate for p53 and Ki-67, and (3) negative expression of p21(WAF1/CIP1). Conclusions: The immunohistochemical findings for UEC showed its high cell-proliferative activity and a high potential for metastasis. Clinical features of UEC were supported by the results of immunohistochemical Endings.
引用
收藏
页码:204 / 209
页数:6
相关论文
共 51 条
  • [1] p53 Overexpression in squamous cell carcinoma of the esophagus
    Baron, PL
    Gates, CE
    Reed, CE
    Dikeman, RLD
    Drosieko, JJ
    Passmore, RN
    Bromberg, JS
    Willingham, MC
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (01) : 37 - 45
  • [2] BASHER MA, 1990, DIGEST DIS SCI, V35, P145
  • [3] PROGNOSTIC VALUE OF DNA INDEX, S-PHASE FRACTION AND P53 PROTEIN ACCUMULATION AFTER SURGICAL RESECTION OF ESOPHAGEAL SQUAMOUS-CELL CARCINOMAS IN THAILAND
    CHANVITAN, A
    NEKARDA, H
    CASSON, AG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) : 381 - 386
  • [4] Chino O, 1998, J SURG ONCOL, V67, P18, DOI 10.1002/(SICI)1096-9098(199801)67:1<18::AID-JSO4>3.0.CO
  • [5] 2-P
  • [6] Coggi G, 1997, CANCER, V79, P425, DOI 10.1002/(SICI)1097-0142(19970201)79:3<425::AID-CNCR1>3.0.CO
  • [7] 2-H
  • [8] COOPER K, 1995, CELL VISION, V2, P49
  • [9] DOKI Y, 1993, CANCER RES, V53, P3421
  • [10] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825